Corvus Pharmaceuticals Market Sentiment

Market sentiment signals for Corvus Pharmaceuticals (CRVS): analyst consensus, short interest, options flow and insider activity.

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Apr 17, 2026	Goldman Sachs	Paul Choi—	+168.3%	$40	Initiate	Buy
Mar 13, 2026	Oppenheimer	Jeff Jones—	+121.3%	$32 → $33	Maintained	Outperform
Jan 22, 2026	Jefferies	Roger Song—	+181.7%	$13 → $42	Maintained	Buy
Jan 21, 2026	Oppenheimer	Jeff Jones—	+114.6%	$15 → $32	Maintained	Outperform
Jan 21, 2026	Barclays	Etzer Darout—	+87.8%	$16 → $28	Maintained	Overweight
Jan 20, 2026	HC Wainwright & Co.	Sean Lee—	+81.1%	$11 → $27	Maintained	Buy
Oct 13, 2025	Barclays	Etzer Darout—	+7.3%	$16	Initiate	Overweight
May 20, 2025	Mizuho	Graig Suvannavejh—	-26.2%	$12 → $11	Maintained	Outperform
May 9, 2025	Oppenheimer	Jeff Jones—	+14.0%	$15 → $17	Maintained	Outperform
Mar 26, 2025	Oppenheimer	Jeff Jones—	+0.6%	$14 → $15	Maintained	Outperform
Mar 26, 2025	HC Wainwright & Co.	Sean Lee—	-26.2%	$11 → $11	Maintained	Buy
Jan 14, 2025	HC Wainwright & Co.	Sean Lee—	-26.2%	$11 → $11	Maintained	Buy
Jan 2, 2025	HC Wainwright & Co.	Sean Lee—	-26.2%	$11	Initiate	Buy
Nov 13, 2024	Oppenheimer	Jeff Jones—	-6.1%	$8 → $14	Maintained	Outperform
Oct 22, 2024	Mizuho	Graig Suvannavejh—	-19.5%	$4 → $12	Upgrade	Neutral→Outperform
Sep 16, 2024	Ladenburg Thalmann	Aydin Huseynov—	+40.8%	$12 → $21	Maintained	Buy
May 7, 2024	Oppenheimer	Jeff Jones—	-46.3%	$7 → $8	Maintained	Outperform
Apr 1, 2024	Cantor Fitzgerald	Li Watsek—	—	—	Maintained	Overweight
Mar 27, 2024	Mizuho	Graig Suvannavejh—	-76.5%	$4 → $4	Maintained	Neutral
Mar 20, 2024	Oppenheimer	Jeff Jones—	-53.1%	$8 → $7	Maintained	Outperform
Sep 7, 2023	Cantor Fitzgerald	Li Watsek—	-73.2%	$4	Maintained	Overweight